Animas Vibe Insulin Pump with Latest Dexcom CGM Technology Now Available in Canada

BURNABY, British Columbia - Animas Canada, a division of LifeScan Canada Ltd., today announced the launch of the Animas® Vibe™ insulin pump and CGM system in Canada, providing a new diabetes management solution for Canadians living with Type 1 diabetes.

Animas® Vibe™ is an insulin pump with integrated continuous glucose monitoring (CGM), featuring the Dexcom G4® sensor, the latest sensor technology from Dexcom. The launch of Animas® Vibe™ marks the first time this advanced CGM sensor technology from Dexcom is available as an integrated system with a pump to Canadians. Continuous glucose monitoring with Animas® Vibe™ is indicated for adults ages 18 years and older only.

In celebration of the Animas® VibeTM launch, Animas Canada is supporting Outrun Diabetes, a project spearheaded by world renowned Canadian athlete and adventurer Sebastien Sasseville who has been living with Type 1 diabetes since 2002. He calls it "a run across Canada to Outrun Diabetes" and plans to run 7,500 km solo – the equivalent of 180 marathons – in nine months across Canada. The goal of this initiative is to inspire Canadians living with diabetes to live their lives to the fullest and not let diabetes stand in the way of pursuing their highest potential. Sasseville will depart on Feb. 2, 2014, from St. John's, Newfoundland and conclude his run on World Diabetes Day (Nov. 14, 2014) in Vancouver, British Columbia. Along the way, Sasseville will be making many stops in cities across Canada and will be participating in hundreds of community events. There will also be opportunities for members of the public to run with Sasseville at points along his route.

Expanding the global presence of Animas® Vibe™ has been a top priority for Animas, and today marks its introduction to North America. Animas® Vibe™ is also currently available in Europe, Australia, and New Zealand.

Key Facts:

Animas Corporation has launched Animas® Vibe™, the only continuous glucose monitoring (CGM)-enabled insulin pump system with Dexcom G4® CGM sensor technology, in Canada.
Animas® Vibe™ brings together world class Animas® insulin pump technology with the most advanced CGM sensor technology available from Dexcom.

CGM technology has been shown to provide improved glycemic control in adult patients over 25 via lower HbA1c levels, less frequent hypoglycemia, and reduced glucose variability.[3]
Animas® Vibe™ is the first and only CGM-enabled insulin pump with a high-contrast colour screen, featuring colour-coded trend lines and arrows to indicate direction and rate of glucose change, revealing trends at a glance.

Sebastien Sasseville is the first Canadian to wear the Animas® Vibe™ insulin pump and CGM system, and will be embarking on a solo cross-Canada run on February 2, 2014.
Continuous glucose monitoring with Animas® Vibe™ is indicated for adults 18 years and older only.


Paul Flynn, North American Sales Director, Animas Corporation, said: "The addition of Animas® Vibe™ to our insulin pump portfolio in Canada demonstrates our commitment to bringing world class technology solutions to people living with diabetes. At Animas, we know that diabetes is not 'one size fits all,' and the ability to choose a pump that best suits a patient's individual needs is critical to successful disease management."

Dr. Brian Levy, Chief Medical Officer, Animas Corporation, said: "Clinical studies have shown that patients who use CGM experience significant improvement in blood glucose control.[4] The launch of Animas® Vibe™ in Canada provides a new option for patients looking for an insulin delivery system with CGM capabilities."

Sebastien Sasseville, Outrun Diabetes, said: "I'm thrilled to have Animas support this project as I know they share a passion for encouraging people with diabetes to live life to the fullest. And for my personal diabetes management, I'm excited to now have Dexcom's CGM technology integrated into an Animas® pump, and couldn't be more proud to be the first Canadian to wear the Animas® Vibe™!"

To learn more about Animas in Canada, visit

Suggested Articles

Lab inside ST fab in Singapore will bring together scientists from A * STAR Institute of Microelectronics and Japan’s ULVAC

The rush to test ventilators was “like sprinting down a pier while also building the pier”

Xilinx stock gained 7% on news of the $35 billion deal while AMD dropped nearly 5%.